| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
4,210,000 |
| Market
Cap: |
1.85(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.44 - $0.44 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Qualigen Therapeutics is a life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. Co.'s drug compound QN-302 is being developed to target regulatory regions of cancer genes that down-regulate gene expression in multiple cancer pathways. Co.'s anticancer drug candidate, QN-247 is aptamer-based and in development to treat a variety of cancer types, including liquid and solid tumors. Co.'s RAS-F portfolio is designed to suppress the interaction of endogenous RAS with c-RAF, upstream of the KRAS, HRAS and NRAS effector pathways.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
30,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$17,100 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Foehr Matthew W |
Director |
– • – |
2017-05-18 |
4 |
B |
$0.62 |
$11,155 |
D/D |
18,000 |
35,000 |
2.39 |
- |
|
| Step Michael D |
CEO |
• • – |
2017-05-11 |
4 |
B |
$0.62 |
$8,007 |
I/I |
13,000 |
50,000 |
2.58 |
- |
|
| Step Michael D |
CEO |
• • – |
2017-02-27 |
4 |
B |
$2.64 |
$26,480 |
I/I |
10,000 |
37,000 |
2.66 |
- |
|
| Merino William M. |
Director |
– • – |
2017-01-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,398 |
|
- |
|
| Ritter Ira E. |
Exec. Chairman, CSO |
• • • |
2016-02-22 |
4 |
B |
$1.60 |
$10,000 |
I/I |
6,250 |
6,250 |
2.56 |
- |
|
| Ritter Andrew J |
President |
• • • |
2016-02-22 |
4 |
B |
$1.60 |
$10,000 |
D/D |
6,250 |
6,250 |
3.15 |
- |
|
| Foehr Matthew W |
Director |
– • – |
2016-01-08 |
4 |
B |
$1.64 |
$21,320 |
D/D |
13,000 |
17,000 |
2.39 |
- |
|
| Step Michael D |
CEO |
• • – |
2016-01-07 |
4 |
B |
$1.48 |
$39,960 |
D/D |
27,000 |
27,000 |
2.81 |
- |
|
| Ritter Ira E. |
Exec. Chairman, CSO |
• • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
817,272 |
817,272 |
|
- |
|
| Stonehenge Partners Llc |
10% Owner |
– – • |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
817,272 |
817,272 |
|
- |
|
| Javelin Venture Partners I Spv I, Llc |
10% Owner |
– – • |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
322,753 |
322,753 |
|
- |
|
| Ritter Andrew J |
President |
• • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
817,272 |
817,272 |
|
- |
|
| Doyle Noah |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,570,557 |
322,753 |
|
- |
|
| Javelin Venture Partners, L.p. |
10% Owner |
– – • |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,247,804 |
2,047,804 |
|
- |
|
| Doyle Noah |
Director |
– • – |
2015-06-24 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
22,727 |
|
- |
|
| Proehl Gerald T |
Director |
– • – |
2015-06-24 |
4 |
B |
$5.00 |
$250,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| Javelin Venture Partners, L.p. |
10% Owner |
– – • |
2015-06-24 |
4 |
B |
$5.00 |
$4,000,000 |
D/D |
800,000 |
800,000 |
2.45 |
- |
|
| Foehr Matthew W |
Director |
– • – |
2015-06-24 |
4 |
B |
$5.00 |
$20,000 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| Doyle Noah |
Director |
– • – |
2015-06-24 |
4 |
B |
$5.00 |
$4,000,000 |
I/I |
800,000 |
800,000 |
2.1 |
- |
|
44 Records found
|
|
Page 2 of 2 |
|
|
